French Observational Xagrid (FOX) Study In Adult Patients With Essential Thrombocythemia
NCT01192347 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177
Last updated 2021-06-14
Summary
This is an observational study to explore how different treatment regimens affect continuation with treatment in the first 6 months following initiation of XAGRID into adult patients' essential thrombocythemia therapy.
Conditions
- Essential Thrombocythemia
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-13
- Primary Completion
- 2012-12-21
- Completion
- 2012-12-21
Countries
- France
Study Locations
More Related Trials
-
Assessment of FOXP3 Gene Polymorphisms and Serum Interleukin 10 in Patients With ITP
NCT05410249 ·Status: UNKNOWN
-
Anagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
NCT01230775 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00037791 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).
NCT04188379 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients
NCT02851407 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
NCT03638817 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy
NCT03517501 ·Status: WITHDRAWN ·Phase: PHASE3
-
Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.
NCT01791101 ·Status: COMPLETED ·Phase: PHASE2
-
The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
NCT03673215 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
NCT00726232 ·Status: TERMINATED ·Phase: PHASE2
-
Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera
NCT01243073 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Human T Lymphoid Progenitor (HTLP) Injection After Partially HLA Compatible Allogeneic Hematopoietic Stem Cell Transplantation in SCID Patients
NCT03879876 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)
NCT03828942 ·Status: COMPLETED
-
A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
NCT02323178 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A
NCT03700229 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
NCT06079879 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
NCT03123588 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)
NCT04274452 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects
NCT03097341 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib
NCT03952039 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib
NCT03755518 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation
NCT01882387 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome
NCT02333760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
NCT04812925 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP
NCT02566603 ·Status: TERMINATED ·Phase: PHASE1/PHASE2